Difference between revisions of "Henry A. McKinnell, Jr."

From Powerbase
Jump to: navigation, search
 
Line 1: Line 1:
"Dr. Henry A. McKinnell Jr. became chief executive officer of [[Pfizer]] in January 2001 and chairman of the board in April 2001 after holding a series of senior executive positions spanning more than 32 years with the company. During his time at Pfizer, McKinnell helped turn the company from a leader in the pharmaceutical industry into a "transforming force" with the acquisitions of Warner-Lambert in 2000 and Pharmacia in 2003 and the subsequent successful integration of both firms, forming a behemoth that earned $45 billion in 2003. Observers described McKinnell as polished, stately, and avuncular, yet also exacting, passionate, and sometimes impatient." {[ref|1}}
+
"Dr. Henry A. McKinnell Jr. became chief executive officer of [[Pfizer]] in January 2001 and chairman of the board in April 2001 after holding a series of senior executive positions spanning more than 32 years with the company. During his time at Pfizer, McKinnell helped turn the company from a leader in the pharmaceutical industry into a "transforming force" with the acquisitions of Warner-Lambert in 2000 and Pharmacia in 2003 and the subsequent successful integration of both firms, forming a behemoth that earned $45 billion in 2003. Observers described McKinnell as polished, stately, and avuncular, yet also exacting, passionate, and sometimes impatient." {{ref|1}}
  
 
He is also chairman of the Governance and Compensation Committee and is a member of the Audit Committee of the Board of Directors. {{ref|2}}
 
He is also chairman of the Governance and Compensation Committee and is a member of the Audit Committee of the Board of Directors. {{ref|2}}

Latest revision as of 15:51, 4 June 2007

"Dr. Henry A. McKinnell Jr. became chief executive officer of Pfizer in January 2001 and chairman of the board in April 2001 after holding a series of senior executive positions spanning more than 32 years with the company. During his time at Pfizer, McKinnell helped turn the company from a leader in the pharmaceutical industry into a "transforming force" with the acquisitions of Warner-Lambert in 2000 and Pharmacia in 2003 and the subsequent successful integration of both firms, forming a behemoth that earned $45 billion in 2003. Observers described McKinnell as polished, stately, and avuncular, yet also exacting, passionate, and sometimes impatient." [1]

He is also chairman of the Governance and Compensation Committee and is a member of the Audit Committee of the Board of Directors. [2]

Since 2002, he is a member of the Board of Directors [3] of ExxonMobil, the world's largest integrated oil company. See also Sourcewatch on ExxonMobil

He is also Vice President of the International Federation of Pharmaceutical Manufacturers and Associations.

He "earns more than $20m a year and was named 11th in the Fortune rankings of the world's most powerful business leaders." [4]

External links

Notes

  1. ^ Moodys Website Shareholder Information
  2. ^ Reference for Business McKinnell Biography
  3. ^ Sarah Boseley 'We just had to act over Aids', The Guardian, September 23, 2004